OMEICOS Therapeutics jobs and careers
Berlin, Germany
About OMEICOS Therapeutics
OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.
Founded in 2013 by Karen Uhlmann and Robert Fischer.
- Founded
- 2013
- Employees
- 11 to 50
- Total funding
- $37.3M
- Headquarters
- Berlin
Leadership
The top of OMEICOS Therapeutics's org chart, with how many people report into each leader.
Robert Fischer
Co-Founder, CEO & CSO
8 reports
Karen Uhlmann
Vice President Operations & IP
3 reports
Edita Bade
Head of Finance & Controlling
Markus Henrich
Consultant, Medicinal Chemistry & CMC
Simon Russell
Chief Business Officer
Dr. Dipl.-Ing. (FH) Martin Liss
R&D Scientist
Board
Christian Schneider
Board Member
Peter Seiler
Board Member
Taro Inaba
Board Member
Wolf-Hagen Schunck
Board Member
Bernhard Kirschbaum
Supervisory Board Chairman
Jobs at OMEICOS Therapeutics
No open positions right now. Explore more companies on TheJobsMap.